Delivery Order SPE2DR25D3201-SPE2DR26FT5FC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.06 to AmerisourceBergen Drug Corp for BSS Plus Eye Irrigation Solution 500ml on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this award reflects AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.76 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of BSS Plus Eye Irrigation Solution in 500ml units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.34 to AmerisourceBergen Drug Corp for BSS Plus Eye Irrigation Solution 500ml, with an ultimate completion date of October 30, 2025. This firm fixed price contract, awarded on October 29, 2025, represents a non-competitive set-aside order fulfilling medical supply needs for federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BSS Plus Eye Irrigation Solution 500ML with a ceiling value of $1,018.64 under a firm fixed-price contract type. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, with no set-aside designation used. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this medical supply delivery. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,401.99 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, competitively awarded contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $12,492.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for Miebo 100% eye drop solution in 3ml quantities. The contract was competitively awarded with no set-aside designation and is scheduled for completion by January 8, 2026. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a delivery order valued at $2,880.44 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3mL) on August 19, 2025, with completion expected by August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $4,120.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of January 8, 2026. This delivery order, designated as a child contract, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's broader contractual relationship with...
- The Defense Logistics Agency awarded a $6,181.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of the same day. This delivery order, designated as a non-set-aside award, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The contract vehicle supports global...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.63 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is structured to support the military healthcare supply chain by delivering pharmaceutical...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5FCDelivery Order
The Defense Logistics Agency awarded a $2,407.35 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of BSS Eye Solution 15ML, with an ultimate completion date of January 9, 2026. This firm fixed-price, non-set-aside delivery order is performed from the vendor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031, which serves as the primary vehicle for pharmaceutical and medical supply procurement across military healthcare systems globally. AmerisourceBergen operates as a critical pharmaceutical distributor and healthcare solutions provider within the federal medical supply chain, with demonstrated capability to deliver a comprehensive range of pharmaceutical products and medical commodities to support military treatment facilities and other government healthcare institutions. This specific delivery order reflects the company's routine fulfillment of small-value medical supply requirements under its existing master contract vehicle, consistent with its established pattern of competitively awarded, firm fixed-price orders spanning therapeutic domains from specialty medications to basic medical consumables. The DLA Troop Support Medical's pharmaceutical procurement strategy leverages such prime vendor relationships to ensure reliable access to essential medical products for Defense Department operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/7/26 |